Sher Leo, Cooper Thomas B, Mann J John, Oquendo Maria A
Division of Neuroscience, Department of Psychiatry, Columbia University, New York, NY 10032, USA.
Int J Adolesc Med Health. 2006 Jan-Mar;18(1):133-7. doi: 10.1515/ijamh.2006.18.1.133.
The key neuroendocrine component of a response to stress is the hypothalamic-pituitary-adrenocortical (HPA) system. Abnormalities in the HPA system have been implicated in the pathophysiology of psychiatric disorders such as depression, post-traumatic stress disorder, alcoholism and suicide. The dexamethasone suppression test (DST) is the most frequently used test to assess HPA-system function in psychiatric disorders. This neuroendocrine test consists of the administration of a low dose of dexamethasone at 11 pm and the measurement of cortisol levels at one or more time points on the following day. After corticotropin-releasing hormone (CRH) became available for clinical studies, the DST was combined with CRH administration. In this test, patients are pretreated with a single dose of dexamethasone at 11 pm and receive human CRH intravenously at 3 pm the following day. The resulting DST-CRH test proved to be much more sensitive in detecting HPA system alterations than the DST. We have modified the DST-CRH test and used ovine CRH instead of human CRH in a pilot study of a group of young healthy volunteers. Results indicated that it produces results similar to the results obtained with human CRH. This suggests that ovine CRH can be used in psychiatric research. Alcoholism is associated with abnormalities in HPA function. Nonalcoholic subjects with a family history of alcoholism exhibit lower plasma ACTH and beta-endorphin as well as lower ACTH, cortisol, and beta-endorphin responses to psychological stress and CRH stimulation. This suggests that in children of alcoholics, alterations in the mechanisms that regulate HPA axis activity predate the development of alcohol dependence and may be considered inherited traits. Therefore, studies of the HPA system in persons at risk for alcoholism may help understand the neurobiological mechanisms of predisposition to alcoholism.
应激反应的关键神经内分泌成分是下丘脑 - 垂体 - 肾上腺皮质(HPA)系统。HPA系统异常与抑郁症、创伤后应激障碍、酒精中毒和自杀等精神疾病的病理生理学有关。地塞米松抑制试验(DST)是评估精神疾病中HPA系统功能最常用的测试。这项神经内分泌测试包括在晚上11点给予低剂量地塞米松,并在第二天的一个或多个时间点测量皮质醇水平。促肾上腺皮质激素释放激素(CRH)可用于临床研究后,DST与CRH给药相结合。在该测试中,患者在晚上11点接受单剂量地塞米松预处理,并在第二天下午3点静脉注射人CRH。结果表明,DST - CRH测试在检测HPA系统改变方面比DST敏感得多。我们对DST - CRH测试进行了改良,并在一组年轻健康志愿者的初步研究中使用了羊CRH代替人CRH。结果表明,其产生的结果与人CRH获得的结果相似。这表明羊CRH可用于精神病学研究。酒精中毒与HPA功能异常有关。有酒精中毒家族史的非酒精性受试者表现出较低的血浆促肾上腺皮质激素(ACTH)和β - 内啡肽,以及对心理应激和CRH刺激的较低ACTH、皮质醇和β - 内啡肽反应。这表明在酗酒者的子女中,调节HPA轴活性的机制改变早于酒精依赖的发展,可能被视为遗传特征。因此,对有酒精中毒风险人群的HPA系统研究可能有助于理解酒精中毒易感性的神经生物学机制。